Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R Harrap

Showing results (101-110 of 138) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
European School of Oncology Task Force Report. New approaches in cancer pharmacology: drug design and development (Part 2)P Workman, M D'Incalci, W Bursch, et al.
British Journal of Cancer|April 1, 1989
Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexesC A Hills, L R Kelland, G Abel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activationC J Rutty, I R Judson, G Abel, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 1, 1995
Determination of metabolites of a novel platinum anticancer drug JM216 in human plasma ultrafiltratesG K Poon, P Mistry, F I Raynaud, et al.
European Journal of Cancer|January 1, 1981
A potent antitumour quinazoline inhibitor of thymidylate synthetase: synthesis, biological properties and therapeutic results in miceT R Jones, A H Calvert, A L Jackman, et al.
Cancer Research|April 1, 1984
Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal functionS J Harland, D R Newell, Z H Siddik, et al.
Biochemical and Biophysical Research Communications|October 29, 1982
Chlorambucil-induced changes in chromatin methylation and their modulation by sodium butyrateM L Ramirez, C R Shepherd, S D Pinsky, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
The antitumour activity of ZD9331, a non-polyglutamatable quinazoline thymidylate synthase inhibitorA L Jackman, R Kimbell, M Brown, et al.
Biochemical Pharmacology|February 15, 1988
Inhibition of human leukaemic thymidylate kinase and L1210 ribonucleotide reductase by dinucleotides of adenosine and thymidine and their phosphonate analoguesR M Orr, L C Davies, J A Stock, et al.
British Journal of Cancer|May 1, 1993
Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodentsM J McKeage, S E Morgan, F E Boxall, et al.
Pageof 14

Showing results (101-110 of 138) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
European School of Oncology Task Force Report. New approaches in cancer pharmacology: drug design and development (Part 2)P Workman, M D'Incalci, W Bursch, et al.
British Journal of Cancer|April 1, 1989
Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexesC A Hills, L R Kelland, G Abel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activationC J Rutty, I R Judson, G Abel, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 1, 1995
Determination of metabolites of a novel platinum anticancer drug JM216 in human plasma ultrafiltratesG K Poon, P Mistry, F I Raynaud, et al.
European Journal of Cancer|January 1, 1981
A potent antitumour quinazoline inhibitor of thymidylate synthetase: synthesis, biological properties and therapeutic results in miceT R Jones, A H Calvert, A L Jackman, et al.
Cancer Research|April 1, 1984
Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal functionS J Harland, D R Newell, Z H Siddik, et al.
Biochemical and Biophysical Research Communications|October 29, 1982
Chlorambucil-induced changes in chromatin methylation and their modulation by sodium butyrateM L Ramirez, C R Shepherd, S D Pinsky, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
The antitumour activity of ZD9331, a non-polyglutamatable quinazoline thymidylate synthase inhibitorA L Jackman, R Kimbell, M Brown, et al.
Biochemical Pharmacology|February 15, 1988
Inhibition of human leukaemic thymidylate kinase and L1210 ribonucleotide reductase by dinucleotides of adenosine and thymidine and their phosphonate analoguesR M Orr, L C Davies, J A Stock, et al.
British Journal of Cancer|May 1, 1993
Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodentsM J McKeage, S E Morgan, F E Boxall, et al.
Pageof 14